Teladoc Health, Inc. (NYSE:TDOC) Stock Holdings Decreased by Invesco Ltd.

Invesco Ltd. cut its stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 63.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 291,923 shares of the health services provider's stock after selling 510,854 shares during the quarter. Invesco Ltd. owned about 0.17% of Teladoc Health worth $2,654,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in TDOC. Versant Capital Management Inc grew its holdings in Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock valued at $29,000 after purchasing an additional 2,441 shares during the last quarter. Whipplewood Advisors LLC acquired a new stake in Teladoc Health in the 4th quarter valued at about $29,000. Lindbrook Capital LLC increased its holdings in Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after acquiring an additional 1,612 shares in the last quarter. Pilgrim Partners Asia Pte Ltd acquired a new position in Teladoc Health during the fourth quarter worth about $60,000. Finally, Generali Investments Management Co LLC purchased a new stake in shares of Teladoc Health in the fourth quarter valued at about $64,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Insider Buying and Selling

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now owns 64,308 shares in the company, valued at $541,473.36. This trade represents a 14.62 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.58% of the stock is owned by corporate insiders.

Teladoc Health Trading Up 1.1 %

Shares of Teladoc Health stock traded up $0.08 during trading hours on Friday, reaching $7.07. The stock had a trading volume of 6,366,764 shares, compared to its average volume of 6,258,945. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 1 year low of $6.35 and a 1 year high of $15.21. The firm has a market capitalization of $1.24 billion, a price-to-earnings ratio of -1.23 and a beta of 1.73. The firm has a 50 day simple moving average of $8.02 and a two-hundred day simple moving average of $9.49.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.49 million during the quarter, compared to analysts' expectations of $639.44 million. As a group, equities research analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts recently issued reports on TDOC shares. Piper Sandler cut their price objective on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. Oppenheimer reduced their price objective on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research report on Friday, January 24th. The Goldman Sachs Group dropped their price objective on Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a research note on Thursday. Finally, Bank of America decreased their price target on shares of Teladoc Health from $9.50 to $8.00 and set a "neutral" rating on the stock in a research note on Friday, April 11th. Eleven equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $9.81.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.